CFG
BEAT

Citizens Financial Group’s BioTelemetry, Inc. BEAT Stock Holding History

Citizens Financial Group’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-600
Closed -$23K – 1251
2020
Q1 		$23K Hold
600
– – ﹤0.01% 586
2019
Q4 		$28K Hold
600
– – ﹤0.01% 557
2019
Q3 		$24K Hold
600
– – ﹤0.01% 450
2019
Q2 		$29K Hold
600
– – ﹤0.01% 413
2019
Q1 		$38K Buy
+600
New +$41.2K ﹤0.01% 386

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citizens Financial Group's BEAT Position: Q2 2020 in Review

Citizens Financial Group sold out of BioTelemetry, Inc. (BEAT) in Q2 2020, closing a stake of 600 shares — an estimated $23K sold.

Citizens Financial Group first reported a position in BEAT in Q1 2019 and held it in 5 quarters. The position peaked at $38K in Q1 2019. 215 funds tracked by Wall St. Rank hold BEAT as of Q2 2020.

  • Citizens Financial Group reported no remaining BioTelemetry, Inc. position as of Q2 2020 after selling out during the quarter.
  • Citizens Financial Group sold 600 BioTelemetry, Inc. shares in Q2 2020, an estimated $23K.
  • Citizens Financial Group first reported a position in BioTelemetry, Inc. in Q1 2019 and held it in 5 quarters.
  • Citizens Financial Group's BioTelemetry, Inc. position peaked at $38K in Q1 2019.
  • 215 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q2 2020.

Based on Citizens Financial Group's 13F filing for Q2 2020, filed 12 Aug 2020.